Monitoring glycemic control: The cornerstone ofdiabetes care

Clinical Therapeutics

Volumn 27, Issue 10, 2005, Pages 1489-1499

  LeRoith, Derek ^a,c   Smith, Deirdre O ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood glucose self monitoring; Diabetes mellitus; Glycemic control; Glycosylated hemoglobin; Hypoglycemia; Monitoring devices

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; BIGUANIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; MIGLITOL; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

ACCURACY; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DEVICE; DIABETES CONTROL; DIABETIC DIET; DRUG EFFECT; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HEALTH PRACTITIONER; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL LITERATURE; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; REVIEW; SELF MONITORING; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

EID: 28444489240     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.10.010     Document Type: Article

References (47)

1. Available at: Centers for Disease Control and Prevention National diabetes fact sheet. General information Accessed January 12 2004
2. Available at US Dept of Health & Human Services HHS, ADA warn Americans of "pre-diabetes," encourage people to takehealthy steps to reduce risks Accessed March 27 2002
3. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 Suppl 1 2005 S4 S36
4. Available at: American Diabetes Association All about diabetes Accessed April 7 2005
5. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
6. Stratton I.M., Adler A.I., and Neil H.A. Association of glycaemia with macrovascular and microvascular complications oftype 2 diabetes (UKPDS 35): Prospective observational study BMJ 321 2000 405 412
7. [published correction appears in Lancet. 1999;354:602] UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33) Lancet 352 1998 837 853
8. American College of Endocrinology consensus statement on guidelines for glycemic control Endocr Pract 8 Suppl 1 2002 5 11
9. Fonseca V. Applying standards of care Cefalu W.T. Gerich J.E. LeRoith D. The CADRE Handbook of Diabetes Management 2004 CMD Publishing New York 53 69
10. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management - 2002 update Endocr Pract 8 Suppl 1 2002 40 82
11. Feinglos M.N., and Bethel M.A. Oral agent therapy in the treatment of type 2 diabetes Diabetes Care 22 Suppl 3 1999 C61 C64
12. Wright A., Burden A.C., Paisey R.B. U.K. Prospective Diabetes Study Group Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in pa tients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) Diabetes Care 25 2002 330 336
13. Khaw K.T., Wareham N., and Luben R. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and nutrition (EPIC-Norfolk) BMJ 322 2001 15 18
14. Ohkubo Y., Kishikawa H., and Araki E. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetesmellitus: A randomized prospective 6-year study Diabetes Res Clin Pract 28 1995 103 117
15. Lepore M., Pampanelli S., and Fanelli C. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente humaninsulin and continuous subcutaneous infusion of insulin lispro Diabetes 49 2000 2142 2148
16. 45-11647. June 30, Texas Diabetes Council Insulin algorithm for type 2 diabetes mellitus in children and adults 2004
17. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 2004 335 342
18. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c) Diabetes Care 26 2003 881 885
19. Rohlfing C.L., Wiedmeyer H.M., and Little R.R. Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial Diabetes Care 25 2002 275 278
20. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia Arch Intern Med 163 2003 1306 1316
21. Saaddine J.B., Engelgau M.M., and Beckles G.L. A diabetes report card for the United States: Quality of care in the 1990s Ann Intern Med 136 2002 565 574
22. Wisdom K., Fryzek J.P., and Havstad S.L. Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: Opportunity for improvement.Findings from a large urban health maintenance organization Diabetes Care 20 1997 971 977
23. Goldstein D.E., Little R.R., and Lorenz R.A. Tests of glycemia in diabetes Diabetes Care 27 Suppl 1 2004 S91 S93
24. Masharani U., and Karam J.H. Diabetes mellitus and hypoglycemia Tierney L.M. McPhee S.J. Papadakis M.A. Current Medical Diagnosis and Treatment 2002 Lange Medical Books/McGraw-Hill New York 1203 1250
25. American Diabetes Association Medical Management of Type 1 Diabetes 4th ed. 2003 ADA Alexandria, Va
26. Strowig S.M., and Raskin P. Improved glycemic control in intensively treated type 1 diabetic patients using blood glucose meters with storage capability and computer-assisted analyses Diabetes Care 21 1998 1694 1698
27. Evans J.M., Newton R.W., and Ruta D.A. Frequency of blood glucose monitoring in relation to glycaemic control: Observational study with diabetes database BMJ 319 1999 83 86
28. Edelman S.V., and Henry R.R. Diagnosis and Management of Type 2 Diabetes 4th ed. 2001 Professional Communications, Inc Caddo, Okla
29. Available at: US Food & Drug Administration Diabetes information: Glucose meters and diabetes management Accessed April 4 2005
30. Meter comparison chart 2005
31. Jungheim K., and Koschinsky T. Glucose monitoring at the arm: Risky delays of hypoglycemia and hyperglycemia detection Diabetes Care 25 2002 956 960
32. Mazze R.S., Shamoon H., and Pasmantier R. Reliability of blood glucose monitoring by patients with diabetes mellitus Am J Med 77 1984 211 217
33. Gonder-Frederick L.A., Julian D.M., and Cox D.J. Self-measurement of blood glucose. Accuracy of selfreported data and adherence to recommended regimen Diabetes Care 11 1988 579 585
34. Independent field study using A1cNow™ (Pacific Northwest) 2005
35. Cagliero E., Levina E.V., and Nathan D.M. Immediate feedback of HbAlc levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients Diabetes Care 22 1999 1785 1789
36. Purpose of the NGSP 2005
37. Schnedl W.J., Trinker M., and Lipp R.W. HbA1c determination in patients with hemoglobin opathies Diabetes Care 22 1999 368 369
38. Schnedl W.J., Krause R., and Halwachs-Baumann G. Evaluation of HbA1c determination methods in patients with hemoglobinopathies Diabetes Care 23 2000 339 344
39. Snieder H., Sawtell P.A., and Ross L. HbA(1c) levels are genetically determined even in type 1 diabetes: Evidence from healthy and diabetic twins Diabetes 50 2001 2858 2863
40. McCarter R.J., Hempe J.M., Gomez R., and Chalew S.A. Biological variation in HbAlc predicts risk of retinopathy and nephropathy in type 1 diabetes Diabetes Care 27 2004 1259 1264
41. Scottish Study Group for the Care of the Young Diabetic Factors influencing glycemic control in young people with type 1 diabetes in Scotland: A population-based study (DIABAUD2) Diabetes Care 24 2001 239 244
42. Sadur C.N., Moline N., and Costa M. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits Diabetes Care 22 1999 2011 2017
43. Aubert R.E., Herman W.H., and Waters J. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial Ann Intern Med 129 1998 605 612
44. Ciechanowski P.S., Hirsch I.B., and Katon W.J. Interpersonal predictors of HbA(1c) in patients with type 1 diabetes Diabetes Care 25 2002 731 736
45. Delahanty L.M., and Halford B.N. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial Diabetes Care 16 1993 1453 1458
46. Thompson W.G. Early recognition and treatment of glucose abnormalities to prevent type 2 diabetes mellitus and coronary heart disease Mayo Clin Proc 76 2001 1137 1143
47. Windecker R., Heinemann L., and Sawicki P.T. Self monitoring of blood glucose in blind diabetic patients Diabet Med 14 1997 703 706